Paula Kareclas

799 total citations · 1 hit paper
8 papers, 545 citations indexed

About

Paula Kareclas is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Paula Kareclas has authored 8 papers receiving a total of 545 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Surgery, 3 papers in Pulmonary and Respiratory Medicine and 3 papers in Oncology. Recurrent topics in Paula Kareclas's work include Gastric Cancer Management and Outcomes (3 papers), Esophageal Cancer Research and Treatment (3 papers) and Diabetes and associated disorders (2 papers). Paula Kareclas is often cited by papers focused on Gastric Cancer Management and Outcomes (3 papers), Esophageal Cancer Research and Treatment (3 papers) and Diabetes and associated disorders (2 papers). Paula Kareclas collaborates with scholars based in United Kingdom. Paula Kareclas's co-authors include Natalie Cook, John Bridgewater, Jane Blazeby, David Cunningham, Andrea Marshall, Hugo Ford, Daniel Swinson, Fareeda Y. Coxon, Janet Dunn and Ian Chau and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Lancet Oncology.

In The Last Decade

Paula Kareclas

8 papers receiving 535 citations

Hit Papers

1 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Docetaxel versus active symptom control for refractory oesophagogastric adenocarcinoma (COUGAR-02): an open-label, phase 3 randomised controlled trial

2013 405 citations Hugo Ford, Andrea Marshall et al. The Lancet Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Paula Kareclas United Kingdom	7	395	238	236	138	60	8	545
Laura Giannetta Italy	9	432 1.1×	369 1.6×	151 0.6×	95 0.7×	83 1.4×	21	587
J-L. van Laethem Belgium	8	132 0.3×	254 1.1×	265 1.1×	70 0.5×	72 1.2×	14	520
Su‐Shun Lo Taiwan	11	368 0.9×	149 0.6×	259 1.1×	121 0.9×	77 1.3×	16	578
Janet Hong United States	5	271 0.7×	318 1.3×	158 0.7×	113 0.8×	24 0.4×	13	446
Fabiola Lorena Rojas Llimpe Italy	10	498 1.3×	500 2.1×	217 0.9×	135 1.0×	117 1.9×	32	791
David E. Adelberg United States	13	305 0.8×	317 1.3×	170 0.7×	106 0.8×	85 1.4×	37	542
Nadine Röthling Germany	8	495 1.3×	311 1.3×	406 1.7×	81 0.6×	45 0.8×	11	658
Eugenio Fiorentino Italy	15	156 0.4×	149 0.6×	176 0.7×	63 0.5×	209 3.5×	41	572
Teruyuki SAKAGUCHI Japan	7	329 0.8×	344 1.4×	197 0.8×	81 0.6×	200 3.3×	13	651
Vincent Hautefeuille France	13	146 0.4×	364 1.5×	167 0.7×	91 0.7×	33 0.6×	58	508

Countries citing papers authored by Paula Kareclas

Since Specialization

Citations

This map shows the geographic impact of Paula Kareclas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paula Kareclas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paula Kareclas more than expected).

Fields of papers citing papers by Paula Kareclas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paula Kareclas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paula Kareclas. The network helps show where Paula Kareclas may publish in the future.

Co-authorship network of co-authors of Paula Kareclas

This figure shows the co-authorship network connecting the top 25 collaborators of Paula Kareclas. A scholar is included among the top collaborators of Paula Kareclas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paula Kareclas. Paula Kareclas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Truman, Lucy, Marcin Ł. Pękalski, Paula Kareclas, et al.. (2015). Protocol of the adaptive study of IL-2 dose frequency on regulatory T cells in type 1 diabetes (DILfrequency): a mechanistic, non-randomised, repeat dose, open-label, response-adaptive study. BMJ Open. 5(12). e009799–e009799. 15 indexed citations

2.

Waldron-Lynch, Frank, Paula Kareclas, Neil Walker, et al.. (2014). Rationale and study design of the Adaptive study of IL-2 dose on regulatory T cells in type 1 diabetes (DILT1D): a non-randomised, open label, adaptive dose finding trial. BMJ Open. 4(6). e005559–e005559. 26 indexed citations

3.

Ford, Hugo, Andrea Marshall, Jonathan Wadsley, et al.. (2013). COUGAR-02: A randomized phase III study of docetaxel versus active symptom control in advanced esophagogastric adenocarcinoma.. Journal of Clinical Oncology. 31(4_suppl). LBA4–LBA4. 20 indexed citations

4.

Ford, Hugo, Andrea Marshall, John Bridgewater, et al.. (2013). Docetaxel versus active symptom control for refractory oesophagogastric adenocarcinoma (COUGAR-02): an open-label, phase 3 randomised controlled trial. The Lancet Oncology. 15(1). 78–86. 405 indexed citations breakdown →

5.

Cook, Natalie, Andrea Marshall, Jane Blazeby, et al.. (2013). Cougar-02: A randomized phase III study of docetaxel versus active symptom control in patients with relapsed esophago-gastric adenocarcinoma.. Journal of Clinical Oncology. 31(15_suppl). 4023–4023. 9 indexed citations

6.

Cook, Natalie, Bristi Basu, Swethajit Biswas, et al.. (2010). A phase 2 study of vatalanib in metastatic melanoma patients. European Journal of Cancer. 46(15). 2671–2673. 23 indexed citations

7.

Corrie, Pippa, Paula Kareclas, C. Mann, et al.. (2008). A phase II study of PTK787 in metastatic melanoma patients. Journal of Clinical Oncology. 26(15_suppl). 9048–9048. 3 indexed citations

8.

Hill, Anita, Simon H. Ridley, Dirk Eßer, et al.. (2005). Protection of erythrocytes from human complement–mediated lysis by membrane-targeted recombinant soluble CD59: a new approach to PNH therapy. Blood. 107(5). 2131–2137. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact